Literature DB >> 29684429

Simultaneous in vitro generation of human CD34+-derived dendritic cells and mast cells from non-mobilized peripheral blood mononuclear cells.

Pavla Taborska1, Jirina Bartunkova1, Daniel Smrz2.   

Abstract

Dendritic cells (DCs) and mast cells (MCs) are key players of the immune system, often coming in close proximity in peripheral tissues. The interplay of these cells is, however, still poorly understood, especially with regards to human cells. The reason for that is the absence of a well established in vitro human cell-based study system that would allow a simultaneous preparation of both cell types. In this study, we show a method for simultaneous generation of DCs and MCs from CD34+ stem cell progenitors that were isolated from the non-adherent fraction of non-mobilized peripheral blood mononuclear cells of healthy donors. We observed that combining stem cells factor (SCF), IL-3 and GM-CSF in serum-free StemPro-34 medium allowed CD34+ cells isolated from an equivalent of 450 ml of peripheral blood to expand to 10-92 × 106 cells after 7 weeks of culturing. These cultures comprised of 6-53% of DCs and 1-21% of MCs as determined by the expression of, respectively, CD11c/HLA-DR or CD117/FcεRI. The DCs were CD1a-CD14-, did not express co-stimulatory molecules CD80 and CD83 and chemokine receptor CCR7. However, the DCs expressed co-stimulatory molecule CD86, and had a capacity to uptake dextran, phagocyte latex particles and induce alloreactivity. MCs, on the other hand, degranulated after crosslinking of FcεRI-bound IgE as determined by the externalization of CD107b. Collectively, our data show that CD34+-derived human DCs and MCs can be generated in a single culture using CD34+ cells isolated from non-mobilized human peripheral blood and that this method may allow ex vivo studies on DC-MC interplay in human system.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD34; Dendritic cells; Mast cells

Mesh:

Substances:

Year:  2018        PMID: 29684429     DOI: 10.1016/j.jim.2018.04.005

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.

Authors:  Michal Podrazil; Pavla Taborska; Dmitry Stakheev; Michal Rataj; Jan Lastovicka; Alena Vlachova; Petr Pohunek; Jirina Bartunkova; Daniel Smrz
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

2.  The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.

Authors:  Dmitry Stakheev; Pavla Taborska; Zuzana Strizova; Michal Podrazil; Jirina Bartunkova; Daniel Smrz
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

3.  Tumoral and paratumoral NK cells and CD8+ T cells of esophageal carcinoma patients express high levels of CD47.

Authors:  Zuzana Strizova; Jiri Vachtenheim; Martin Snajdauf; Robert Lischke; Jirina Bartunkova; Daniel Smrz
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

4.  SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.

Authors:  Pavla Taborska; Jan Lastovicka; Dmitry Stakheev; Zuzana Strizova; Jirina Bartunkova; Daniel Smrz
Journal:  Immun Inflamm Dis       Date:  2021-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.